Education
About Us
Working with TipRanks
Follow Us
Adaptimmune Therapeutics (DE:473A)
FRANKFURT:473A
RESEARCH TOOLSreports
Summary of all the Indicators
Overall Consensus
Neutral
8Bullish
6Neutral
8Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
3Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Adaptimmune Therapeutics’s (473A) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Adaptimmune Therapeutics is a Sell.
Adaptimmune Therapeutics’s (473A) 20-Day exponential moving average is 0.24, while Adaptimmune Therapeutics’s (473A) share price is €0.24, making it a Buy.
Adaptimmune Therapeutics’s (473A) 50-Day exponential moving average is 0.26, while Adaptimmune Therapeutics’s (473A) share price is €0.24, making it a Sell.
Adaptimmune Therapeutics (473A) Pivot Points
Classic
0.21
0.22
0.22
0.23
0.23
0.23
0.24
Fibonacci
0.22
0.22
0.22
0.23
0.23
0.23
0.23
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Adaptimmune Therapeutics (473A) Moving Averages
MA5
0.24Buy
0.24Buy
MA10
0.23Buy
0.24Buy
MA20
0.24Buy
0.24Buy
MA50
0.22Buy
0.26Sell
MA100
0.36Sell
0.35Sell
MA200
0.55Sell
0.54Sell
Adaptimmune Therapeutics’s (473A) 10-Day exponential moving average is 0.24, while Adaptimmune Therapeutics’s (473A) share price is €0.24, making it a Buy.
Adaptimmune Therapeutics’s (473A) 100-Day exponential moving average is 0.35, while Adaptimmune Therapeutics’s (473A) share price is €0.24, making it a Sell.
Adaptimmune Therapeutics’s (473A) stock price is €0.24 and Adaptimmune Therapeutics’s (473A) 50-day simple moving average is 0.22, creating a Buy signal.
Adaptimmune Therapeutics’s (473A) stock price is €0.24 and Adaptimmune Therapeutics’s (473A) 100-day simple moving average is 0.36, creating a Sell signal.
Adaptimmune Therapeutics’s (473A) stock price is €0.24 and Adaptimmune Therapeutics’s (473A) 200-day simple moving average is 0.55, creating a Sell signal.
Adaptimmune Therapeutics (473A) Technical Indicators
RSI (14)
51.31
Neutral
STOCH (9,6)
60.78
Neutral
STOCHRSI (14)
41.26
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
34.44
Neutral
Williams %R
-7.41
Sell
CCI (14)
23.34
Neutral
ATR (14)
0.03
-
Ultimate Oscillator
47.98
Neutral
ROC
-40.58
Sell
Adaptimmune Therapeutics’s (473A) Relative Strength Index (RSI) is 51.31, creating a Neutral signal.
Adaptimmune Therapeutics’s (473A) Trend Strength Indicator (ADX) is 34.44, creating a Neutral signal.
Adaptimmune Therapeutics’s (473A) Commodity Channel Index (CCI) is 23.34, creating a Neutral signal.
Adaptimmune Therapeutics’s (473A) Price Rate of Change (ROC) is -40.58, creating a Sell signal.
FAQ
Is 473A a Buy, Hold, or Sell?
Based on 473A’s technical indicators, 473A is a Hold.
What is 473A’s RSI (14)?
473A’s RSI (14) is 51.31, which suggests 473A is a Neutral.
What is 473A’s MACD?
473A’s MACD is >-0.01, which suggests 473A is a Sell.
What is 473A’s 5-day moving average?
473A’s 5-day moving average is 0.24, which suggests 473A is a Buy.
What is 473A’s 20-day moving average?
473A 20-day moving average is 0.24, which suggests 473A is a Buy.
What is 473A’s 50-day moving average?
473A’s 50-day moving average is 0.22, which suggests 473A is a Buy.
What is 473A’s 200-day moving average?
473A’s 200-day moving average is 0.55, which suggests 473A is a Sell.
What is 473A’s Williams % R (14)?
473A’s Williams % R (14) is -7.41, which suggests 473A is a Sell.
What is 473A’s CCI (14)?
473A’s CCI (14) is 23.34, which suggests 473A is a Neutral.
What is the share price of Adaptimmune Therapeutics?